Integrating Immunotherapy Into Chemoradiation for NSCLC Integrating Immunotherapy Into Chemoradiation for NSCLC

Clinicians should consider timing and toxicities when adding a checkpoint inhibitor to chemoradiotherapy for NSCLC.Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news